Page last updated: 2024-11-05

tolbutamide and Hyperandrogenism

tolbutamide has been researched along with Hyperandrogenism in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Hyperandrogenism: A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carbunaru, G1
Prasad, P1
Scoccia, B1
Shea, P1
Hopwood, N1
Ziai, F1
Chang, YT1
Myers, SE1
Mason, JI1
Pang, S1

Other Studies

1 other study available for tolbutamide and Hyperandrogenism

ArticleYear
The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:2

    Topics: 3-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Area Under Curve; Blood Glucose; Female; Glucose

2004